Abdulaziz I Alnasser
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 4
Publications (10 Years): 4
Top Venues
Publications
- Mohamed M Hefnawy, A F M Motiur Rahman, Abdullah M Al-Hossaini, Abdulaziz I Alnasser, Adel S El-Azab, Yousef A Bin Jardan, Mohamed W Attwa, Manal A El-GendyA Rapid and Sensitive Liquid Chromatography-Tandem Mass Spectrometry Bioanalytical Method for the Quantification of Encorafenib and Binimetinib as a First-Line Treatment for Advanced (Unresectable or Metastatic) Melanoma-Application to a Pharmacokinetic Study. Molecules (Basel, Switzerland) 28 (1) (2022)
- Mohamed M Hefnawy, A F M Motiur Rahman, Abdullah M Al-Hossaini, Abdulaziz I Alnasser, Adel S El-Azab, Yousef A Bin Jardan, Mohamed W Attwa, Manal A El-GendyA Rapid and Sensitive Liquid Chromatography-Tandem Mass Spectrometry Bioanalytical Method for the Quantification of Encorafenib and Binimetinib as a First-Line Treatment for Advanced (Unresectable or Metastatic) Melanoma-Application to a Pharmacokinetic Study. Molecules (Basel, Switzerland) 28 (1) (2022)
- Mohamed M Hefnawy, A F M Motiur Rahman, Abdullah M Al-Hossaini, Abdulaziz I Alnasser, Adel S El-Azab, Yousef A Bin Jardan, Mohamed W Attwa, Manal A El-GendyA Rapid and Sensitive Liquid Chromatography-Tandem Mass Spectrometry Bioanalytical Method for the Quantification of Encorafenib and Binimetinib as a First-Line Treatment for Advanced (Unresectable or Metastatic) Melanoma-Application to a Pharmacokinetic Study. Molecules (Basel, Switzerland) 28 (1) (2022)
- Mohamed M Hefnawy, A F M Motiur Rahman, Abdullah M Al-Hossaini, Abdulaziz I Alnasser, Adel S El-Azab, Yousef A Bin Jardan, Mohamed W Attwa, Manal A El-GendyA Rapid and Sensitive Liquid Chromatography-Tandem Mass Spectrometry Bioanalytical Method for the Quantification of Encorafenib and Binimetinib as a First-Line Treatment for Advanced (Unresectable or Metastatic) Melanoma-Application to a Pharmacokinetic Study. Molecules (Basel, Switzerland) 28 (1) (2022)